Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
136
-
Total shares
-
27.9M
-
Shares change
-
+656K
-
Total reported value, excl. options
-
$531M
-
Value change
-
+$12.2M
-
Number of buys
-
60
-
Number of sells
-
-66
-
Price
-
$19.01
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q3 2021
134 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q3 2021.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.9M shares
of 50.5M outstanding shares and own 55.3% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.18M shares), FEDERATED HERMES, INC. (3.47M shares), VANGUARD GROUP INC (2.52M shares), DIMENSIONAL FUND ADVISORS LP (1.74M shares), STATE STREET CORP (1.46M shares), JANUS HENDERSON GROUP PLC (971K shares), Invesco Ltd. (714K shares), GEODE CAPITAL MANAGEMENT, LLC (704K shares), GOLDMAN SACHS GROUP INC (575K shares), and MORGAN STANLEY (517K shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.